These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7889915)

  • 21. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH; Townsend HG; Hannant D
    Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vaccination against the paralytic form of EHV1?].
    Breukink HJ; Binkhorst GJ; van Oirschot JT
    Tijdschr Diergeneeskd; 1983 May; 108(9):359. PubMed ID: 6306862
    [No Abstract]   [Full Text] [Related]  

  • 23. Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)--masters of co-evolution and a constant threat to equids and beyond.
    Ma G; Azab W; Osterrieder N
    Vet Microbiol; 2013 Nov; 167(1-2):123-34. PubMed ID: 23890672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equine herpesvirus-1: dealing practically but effectively with an ever present threat.
    Gonzalez-Medina S; Newton JR
    Equine Vet J; 2015 Mar; 47(2):142-4. PubMed ID: 25644768
    [No Abstract]   [Full Text] [Related]  

  • 25. Investigation of the molecular detection of vaccine-derived equine herpesvirus type 1 in blood and nasal secretions from horses following intramuscular vaccination.
    Pusterla N; Chaney KP; Maes R; Wise AG; Holland R; Schott HC
    J Vet Diagn Invest; 2007 May; 19(3):290-3. PubMed ID: 17459860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses.
    Cornick J; Martens J; Martens R; Crandell R; McConnell S; Kit S
    Can J Vet Res; 1990 Apr; 54(2):260-6. PubMed ID: 2162730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of protective efficacies between intranasal and intramuscular vaccination of horses with a modified live equine herpesvirus type-1 vaccine.
    Bannai H; Nemoto M; Tsujimura K; Yamanaka T; Kokado H; Kondo T; Matsumura T
    Vet Microbiol; 2018 Aug; 222():18-24. PubMed ID: 30080668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.
    Bresgen C; Lämmer M; Wagner B; Osterrieder N; Damiani AM
    Vet Microbiol; 2012 Nov; 160(1-2):9-16. PubMed ID: 22633483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control and disease clearance after neurological EHV-1 in the UK.
    Strang C; Newton R
    Vet Rec; 2017 Dec; 181(25):678-679. PubMed ID: 29269546
    [No Abstract]   [Full Text] [Related]  

  • 30. ADCC and complement-dependent lysis as immune mechanisms against EHV-1 infection in the horse.
    Stokes A; Wardley RC
    Res Vet Sci; 1988 May; 44(3):295-302. PubMed ID: 2841731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W
    Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of equine herpesvirus abortion: searching for clues to the future.
    Gilkerson JR; Love DN; Whalley JM
    Aust Vet J; 1998 Oct; 76(10):675-6. PubMed ID: 9830567
    [No Abstract]   [Full Text] [Related]  

  • 33. EHV-1 and EHV-4 infection in vaccinated mares and their foals.
    Foote CE; Love DN; Gilkerson JR; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):41-6. PubMed ID: 16513181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of equine herpesvirus myeloencephalopathy - Is heparin a novel option? A case report.
    Walter J; Seeh C; Fey K; Bleul U; Osterrieder N
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2016 Oct; 44(5):313-317. PubMed ID: 27652372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equine herpesviruses 1 and 4: creeping to a solution.
    Smith K
    Vet J; 2005 Jul; 170(1):6-7. PubMed ID: 15914048
    [No Abstract]   [Full Text] [Related]  

  • 36. [Several years of diagnostic studies on the EHV 1 abortion in thoroughbred studs following the introduction of vaccination].
    von Benten C; Petzoldt K
    Berl Munch Tierarztl Wochenschr; 1977 May; 90(9):176-80. PubMed ID: 195571
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.
    Wagner B; Goodman LB; Babasyan S; Freer H; Torsteinsdóttir S; Svansson V; Björnsdóttir S; Perkins GA
    Vaccine; 2015 Oct; 33(42):5588-5597. PubMed ID: 26384446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
    Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
    Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of equid herpesvirus 1 for the veterinary practitioner. Part B: pathogenesis and epidemiology.
    Dunowska M
    N Z Vet J; 2014 Jul; 62(4):179-88. PubMed ID: 24597839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [EHV1, to vaccinate or not?].
    Binkhorst GJ; van Oirschot JT; Breukink HJ
    Tijdschr Diergeneeskd; 1985 Mar; 110(5):189-90. PubMed ID: 2984805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.